Novoa-Loyola Jose E. 4
4 · TRIPLE-S MANAGEMENT CORP · Filed Mar 5, 2020
Insider Transaction Report
Form 4
Novoa-Loyola Jose E.
Chief Medical Officer
Transactions
- Award
Class B Common Stock
2020-03-03+23,475→ 52,766 total - Award
Class B Common Stock
2020-03-03+7,187→ 29,291 total
Footnotes (3)
- [F1]Shares acquired represent grant of restricted stock that will vest in equal installments on each of March 3, 2021, 2022 and 2023.
- [F2]The amount of securities beneficially owned reported in Column 5 includes 1,074 Class B Common Stock shares received by the reporting person pursuant to a share dividend issued by Triple-S Management Corporation ("TSM")to all Class B Common Stock shareholders on August 6, 2019.
- [F3]Shares acquired represent common stock earned pursuant to a grant of Performance Shares on March 7, 2017. The Performance Shares resulting in the issuance of these shares of common stock did not constitute derivative securities. As a result, such Performance Shares were not required to be reported and were not reported on a Form 4 at the time of the award.